Winter Park, Florida--(Newsfile Corp. - December 17, 2025) - Adia Labs, a division of Adia Nutrition Inc. (OTCQB: ADIA), today announced a strategic marketing partnership with BoldMD, a leading medical marketing and AI technology company focused on longevity and wellness. The partnership is designed to accelerate the nationwide expansion of Axia MD's innovative chiropractor-hosted pop-up longevity clinics.This collaboration builds on Adia Labs' recently announced partnership with Axia MD, which provides na ...

US stocks rose modestly on Wednesday, looking to snap a three-session losing streak for major benchmarks as investors digested newly released labour market data and comments from Federal Reserve officials. The S&P 500 traded about 0.1% higher, while the Nasdaq Composite also edged up by roughly the same amount. ...

Core Insights - Adagene Inc. (ADAG) received Fast Track designation from the FDA for its lead immuno-oncology candidate, muzastotug (ADG126), in combination with Merck's Keytruda for treating adult patients with microsatellite-stable metastatic colorectal cancer (MSS mCRC) without active liver metastases [1][6] - Following the announcement, ADAG shares increased by 13.8% [1][7] - The Fast Track designation aims to expedite the development and review of therapies for serious diseases with unmet medical needs [2] Company Overview - Muzastotug is a next-generation anti-CTLA-4 antibody developed using proprietary SAFEbody masking technology, which may improve survival and quality of life compared to conventional therapies [5][7] - The ongoing phase II study has primary and secondary endpoints focused on overall response rate, duration of response, progression-free survival, and overall survival [6][8] - A phase III study is planned to start in 2027, contingent on continued positive clinical results [8] Market Performance - Over the past year, ADAG's shares have declined by 6.9%, contrasting with a 16.3% rise in the industry [4] - The Fast Track designation allows for more frequent interactions with the FDA and potential rolling reviews of future marketing applications [8]

Key Takeaways Canadian Natural sets a C$6.3B 2026 capital budget focused on low-cost, long-life assets and returns.CNQ targets 1,590-1,650 MBOE/d in 2026, up about 3% year over year, driven by a 74% liquids mix.Canadian Natural plans 448 net wells, oil sands upgrades and C$125M for carbon capture amid a turnaround.Canadian Natural Resources Limited (CNQ) , one of North America's largest independent producers of crude oil and natural gas, unveiled its budget for 2026. With a clear commitment to maximizing sh ...

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Bitdeer To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in Bitdeer between June 6, 2024 and November 10, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).[You may also click here for additional information]NEW YORK, Dec. 17, 2025 /PRNewswire/ -- Faruqi & Faruqi ...

Core Insights - Financial Serenity focuses on the asset management sector, providing in-depth analysis of market dynamics [1] - The initiative combines data analysis with actionable opinions and ratings on ETFs and trending instruments [1] - The mission is to deliver data-driven perspectives to assist investors in making informed decisions in a changing market [1] Industry Overview - The asset management market is characterized by evolving dynamics that require rigorous data analysis for effective decision-making [1] - Insights from the analysis aim to highlight potential investment opportunities and trends within the asset management space [1]

Joining us right now first on CNBC is Medline CEO Jim Bole. Good morning to you. >> Good morning.>> Congratulations. This been this has been a quite a road for you to get to to this point. Uh why go public now.What's the what's what's the thinking in terms of where you came from and where you are right now. >> And as you know, we've been a private company for 58 years. Um with 58 years of consecutive growth, uh we just feel like this is the right time for us to kind of expand our voice.Historically, we've d ...

Core Insights - Elon Musk's net worth has reached a record $648 billion, with a year-to-date gain of $216 billion, surpassing the entire fortune of LVMH CEO Bernard Arnault [1][2] - Tesla's stock price closed at an all-time high of $490, significantly contributing to Musk's wealth increase, alongside a doubling of SpaceX's valuation to $800 billion [2][5] - Musk's wealth is more than double that of the second richest individual, Larry Page, and exceeds the market values of major companies like Oracle and Mastercard [3][4] Company Performance - Tesla's stock has seen a remarkable recovery, with a significant rally following a period of decline earlier in the year, driven by investor optimism regarding AI and autonomous vehicle development [5][6] - The approval of Musk's pay package by Tesla shareholders could potentially make him the world's first trillionaire if he meets specific performance milestones [8] Industry Trends - The surge in stock prices for Tesla and other major tech companies is largely attributed to the excitement surrounding AI advancements, with Musk investing heavily in AI for Tesla's products [6][7] - Key shareholders in the AI sector, including Musk, have experienced substantial wealth gains, reflecting the broader market trends influenced by AI developments [7]

Back to Squawk on the Street. Time now for a mad dash. Of course, seven minutes before we get started with trading here at the New York Stock Exchange.Let's talk a bit about Apple. >> Right. Okay.Refreshing. Uh two pieces. One by Morgan Stanley.The other by Ben Rice at Melius talking about Well, here's one that the the price target too low. That's Morgan Stanley. They are taking that up to three uh 33.What. 335 from 315. >> Okay.But uh the most important thing I like Melius would just say is listen you want ...

Key Takeaways Western Digital is seeing solid cloud-driven sales growth from rising demand for high-capacity nearline HDDs. Teradata is expanding Agentic AI platforms and analytics tools to boost ARR, productivity and free cash flow.Seagate Technology has nearline capacity largely booked through 2026 on strong cloud and AI demand.The computer storage devices industry players are likely to gain from solid momentum in cloud computing, Internet of Things (IoT), auto, connected devices, virtual reality and arti ...